Choline acetyltransferase of the common type immunoreactivity in the rat brain following different heroin treatments: A pilot study

Journal of Chemical Neuroanatomy

Volumn 41, Issue 2, 2011, Pages 111-121

  Casini, Arianna ^a   Vivacqua, Giorgio ^a   Pontieri, Francesco E ^a   Kimura, Hiroshi ^b   Bellier, Jean P ^b   D'Este, Loredana ^a   Renda, Tindaro G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SHIGA UNIVERSITY   (Japan)

Author keywords

Amygdala; Calretinin 31kDa; Cholinergic system; Drug sensitization; Nucleus accumbens

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DIAMORPHINE;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); DENTATE GYRUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PILOT STUDY; PRIORITY JOURNAL;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DENTATE GYRUS; HEROIN; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NUCLEUS ACCUMBENS; ORGAN SPECIFICITY; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI;

EID: 79551516845     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2010.12.005     Document Type: Article

References (66)

1. Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A., Di Chiara G. Intravenous administration of ecstasy (3, 4-methylendioxymetamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur. J. Pharmacol. 2001, 418:207-211.
2. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv. Rev. Psychiatry 2004, 12:305-320.
3. Bartorelli R., Consolo S. D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 1990, 54:2145-2148.
4. Berke J.D., Eichenbaum H.B. Drug addiction and the hippocampus. Science 2001, 294(5545):1235.
5. Berlanga M.L., Simpson T.K., Alcantara A.A. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release. J. Comp. Neurol. 2005, 492:34-49.
6. Bickerdike M.J., Abercombie E.D. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J. Pharmacol. Exp. Ther. 1997, 282:818-826.
7. Blasco-Ibañez J.M., Freund T.F. Distribution, ultrastructure, and connectivity of calretinin-immunoreactive mossy cells of the mouse dentate gyrus. Hippocampus 1997, 7(3):307-320.
8. Bradberry C.W. Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys and humans: areas of agreement, disagreement and implication for addiction. Psychopharmacology 2007, 191(3):705-717.
9. Butcher L.L., Woolf N.J. Cholinergic neurons and networks revisited. The Rat Nervous System 2004, Elsevier, New York. 3rd ed. G. Paxinos (Ed.).
10. Caine S.B., Koob G.F., Parsons L.H., Everitt B.J., Schwarts J.C., Sokoloff P. D3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuro Report 1997, 8:2373-2377.
11. Chapman P.F., Ramsay M.F., Krezel W., Knevett S.G. Synaptic plasticity in the amygdala: comparisons with hippocampus. Ann. N. Y. Acad. Sci. 2003, 985:114-124.
12. Chen J.C., Chen P.C., Chiang Y.C. Molecular mechanism of psycostimulant addiction. Chang Gung Med. J. 2009, 32(2):148-154.
13. Consolo S., Caltavuturo C., Colli E., Recchia M., Di Chiara G. Different sensitivity of in vivo acetylcholine transmission to D1 receptor stimulation in shell and core of nucleus accumbens. Neuroscience 1999, 89:1209-1217.
14. Crespo J., Sturm K., Saria A., Zernig G. Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J. Neurosci. 2006, 26:6004-6010.
15. D'Este L., Casini A., Pontieri F.E., Renda T.G. Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment. Brain Res. 2006, 1083(1):151-158.
16. D'Este L., Scontrini A., Casini A., Pontieri F.E., Renda T.G. Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum. Brain Res. 2002, 933(2):144-149.
17. Dackis C.A., O'Brien C.P. Cocaine dependence: a disease of the brain's reward centers. J. Subst. Abuse Treat. 2001, 21:111-117.
18. Dalley J.W., Lääne K., Theobald D.E., Armstrong H.C., Corlett P.R., Chudasama Y., Robbins T.W. Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(17):6189-6194.
19. Deller T., Katona I., Cozzari C., Frotscher M., Freund T.F. Cholinergic innervation of mossy cells in the rat fascia dentata. Hippocampus 1999, 9(3):314-320.
20. De Olmos J.S., Beltramino C.A., Alheid G. Amygdala and extended amygdala of the rat: a cytoarchitectonical, fibroarchitectonical, and chemoarchitectonical survey. The Rat Nervous System 2004, Elsevier, New York. 3rd ed. G. Paxinos (Ed.).
21. Di Chiara G., Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr. Opin. Pharmacol. 2007, 7(1):69-76.
22. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004, 47:227-241.
23. Di Chiara G., Tanda G., Bassareo V., Pontieri F., Acquas E., Fenu S., Cadoni C., Carboni E. Drug addictionas a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann. N. Y. Acad. Sci. 1999, 877:461-485.
24. Ersche K.D., Clark L., London M., Robbins T.W., Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006, 31(5):1036-1047.
25. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8(11):1481-1489. (Erratum in: Nat. Neurosci. 9(7) (2006), 979).
26. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann. N. Y. Acad. Sci. 1999, 877:412-438.
27. Fitch T.E., Sahr R.N., Eastwood B.J., Zhou F.C., Yang C.R. Dopamine D1/5 receptor modulation of firing rate and bidirectional theta burst firing in medial septal/vertical limb of diagonal band neurons in vivo. J. Neurophysiol. 2006, 95(5):2808-2820.
28. Fuchs R.A., Feltenstein M.W., See R.E. The role of the basolateral amygdala in stimulus-reward memory and extinction memory consolidation and in subsequent conditioned cued reinstatement of cocaine seeking. Eur. J. Neurosci. 2006, 23(10):2809-2813.
29. Fujise N., Liu Y., Hori N., Kosaka T. Distribution of calretinin immunoreactivity in the mouse dentate gyrus: II. Mossy cells, with special reference to their dorsoventral difference in calretinin immunoreactivity. Neuroscience 1998, 82:181-200.
30. Hasselmo M.E. The role of acetylcholine in learning and memory. Curr. Opin. Neurobiol. 2006, 16(6):710-715.
31. Hirsh R., Davis R.E., Holt L. Fornix-thalamus fibers, motivational states, and contextual retrieval. Exp. Neurol. 1979, 65(2):373-390.
32. Hyman S.E. Addiction: a disease of learning and memory. Am. J. Psychiatry 2005, 162:1414-1422.
33. Imperato A., Obinu M.C., Demontis M.V., Gessa G.L. Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. Eur. J. Pharmacol. 1992, 229:265-267.
34. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 2005, 162(8):1403-1413.
35. Kimura H., McGeer P.L., Peng J.H., McGeer E.G. Choline acetyltransferase-containing neurons in the rat brain. Handbook of Chemical Neuroanatomy. vol. 3: Classical Transmitter and Transmitter Receptors in the CNS. Part 2 1984, 51-67. Elsevier, Amsterdam.
36. Kimura S., Bellier J.-P., Matsuo A., Tooyama I., Kimura H. The production of antibodies that distinguish rat choline acetyltransferase from its splice variant product of a peripheral type. Neurochem. Int. 2007, 50:251-255.
37. Kish S.J., Kalasinsky K.S., Furukawa y., Guttman M., Ang L., Li L., Adams V., Reiber G., Anthony R.A., Anderson W., Smialek J., Di Stefano L. Brain choline acetyltransferase activity in chronic, human, users of cocaine, methamphetamine, and heroin. Mol. Psychiatry 1999, 4(1):26-32.
38. Kitabatake Y., Hikida T., Watanabe D., Pastan I., Nakanishi S. Impairment of reward-related learning by cholinergic ablation in the striatum. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7965-7970.
39. Koob G.F., Le Moal F. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 2005, 8(11):1442-1444.
40. Kotti T., Tapiola T., Riekkinen P.J.S., Miettinen R. The calretinin-containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity-induced neuropathological changes in the gerbil and rat. Eur. J. Neurosci. 1996, 8:2371-2378.
41. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998, 51(1-2):23-47.
42. Kruzich P.J., See R.E. Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. J. Neurosci. 2001, 21(14):155.
43. Le Merrer J., Becker J.A., Befort K., Kieffer B.L. Reward processing by the opioid system in the brain. Physiol. Rev. 2009, 89(4):1379-1412.
44. Lyoo I.K., Pollack M.H., Silveri M.M., Ahn K.H., Diaz C.I., Hwang J., Kim S.J., Yurgelun-Todd D.A., Kaufman M.J., Renshaw P.F. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology 2006, 184(2):139-144.
45. McLaughlin J., See R.E. Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology 2003, 168(1-2):57-65.
46. Meil W.M., See R.E. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav. Brain Res. 1997, 87(2):139-148.
47. Nestler E.J., Berhow M.T., Brodkin E.S. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol. Psychiatry 1996, 1(3):190-199.
48. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J., Robbins T.W. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000, 23(2):113-126.
49. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Academic Press, USA. 6th ed.
50. Pepeu G., Giovannini M.G. Changes in acetylcholine extracellular levels during cognitive processes. Learn. Mem. 2004, 11(1):21-27.
51. Pontieri F.E., Calò L., Di Grezia R., Orzi F., Passarelli F. Functional correlates of heroin sensitization in the rat brain. Eur. J. Pharmacol. 1997, 335(2-3):133-137.
52. Rogers R.E., Higgins S.T., Silverman K., Thomas C.S., Badger G.J., Bigelow G., Stitzer M. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers. Psychol. Addict. Behav. 2008, 22(4):544-550.
53. Schurr A., Rigor B.M., Strong R., Gottesfeld Z. The cholinergic system in rat striatum during morphine tolerance and dependence. Life Sci. 1983, 33(25):2521-2525.
54. See R.E., Fuchs R.A., Ledford C.C., McLaughlin J. Drug addiction, relapse and the amygdala. Ann. N. Y. Acad. Sci. 2003, 985:294-307.
55. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 2004, 47:242-255.
56. Siegal D., Erickson J., Varoqui H., Ang L., Kalasinsky K.S., Peretti F.J., Aiken S.S., Wickham D.J., Kish S.J. Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse 2004, 52(4):223-232.
57. Smith J.E., Co C., Yin X., Sizemore G.M., Liguori A., Johnson W.E., Martin T.J. Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci. Biobehav. Rev. 2004, 27:841-850.
58. Tiffany S.T. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol. Rev. 1990, 97(2):147-168.
59. Tooyama I., Kimura H. A protein encoded by an alternative splice variant of choline acetyltransferase mRNA is localized preferentially in peripheral nerve cells and fibers. J. Chem. Neuroanat. 2000, 17(4):217-226.
60. Whitelaw R.B., Markou A., Robbins T.W., Everitt B.J. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology 1996, 127(3):213-224.
61. Wise R.A. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox. Res. 2008, 14(2-3):169-183.
62. Wise R.A., Rompre P.P. Brain dopamine and reward. Ann. Rev. Psychol. 1989, 40:191-225.
63. Yap J.J., Miczek K.A. Stress and rodent models of drug addiction: role of VTA-accumbens-PFC-amygdala circuit. Drug Discov. Today Dis. Models 2008, 5(4):259-270.
64. You Z.B., Wang B., Zitzman D., Wise R.A. Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J. Neurosci. 2008, 28(36):9021-9029.
65. Zeigler S., Lipton J., Toga A., Ellison G. Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res. 1991, 552(1):27-35.
66. Zhu W., Liu H., Zhang F., Tang S., Zhu H., Lai M., Kalivas P.W. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin seeking induced by conditioned cues. Neuroscience 2007, 144:1209-1218.